Infection Control is designed to prevent health hazards caused due to the spread of diseases to patients and health workers. It occupies a unique position in the patient safety and quality universal health coverage field as it is relevant to health workers and patients at every single health-care encounter.

The infection control market is projected to reach USD 27.5 billion by 2024. Factors contributing to the growth of the infection control market include a rise in hospital-acquired infections, growing surgical procedures, expanding geriatric population, and increasing incidence of chronic diseases.

HIGH INCIDENCE OF HOSPITAL ACQUIRED INFECTIONS TO DRIVE THE GROWTH OF THE INFECTION CONTROL MARKET

	Driver	2–3 Years	3–5 Years	5–8 Years
Drivers	High incidence of hospital-acquired infections	High	High	Moderate
	An increasing number of surgical procedures	High	High	High
	Growing geriatric population and increasing incidence of chronic diseases	High	High	Moderate
	Growing focus on food sterilization and disinfection	High	High	Moderate
	Technological advancements in sterilization equipment	High	Moderate	Moderate
	Increasing outsourcing of sterilization services among pharmaceutical companies, hospitals, and medical device manufacturers	Moderate	High	High
Restraints	Concerns regarding the safety of reprocessed instruments	High	High	Moderate
Opportunities	Growing medical device and pharmaceutical industries in emerging economies	High	High	Moderate
	Increasing use of e-beam sterilization	High	High	Moderate
	Rising importance of single-use medical nonwovens and medical devices	High	Moderate	Moderate
Challenges	Sterilization and disinfection of advanced medical instruments	High	Moderate	Moderate
Challenges	End-user noncompliance with sterilization standards	Moderate	Low	Low

The report identifies and benchmarks key market players in the infection control market including Getinge Group (Sweden), STERIS Corporation (US), Advanced Sterilization Products (US), Ecolab (US), Belimed AG (Switzerland), and evaluates them based on business strategy excellence and strength of product portfolio within the infection control market ecosystem, combining inputs from various industry experts, buyers, and vendors, and extensive secondary research including annual reports, company press releases, investor presentations, free and paid company databases. They are rated and positioned on a 2x2 matrix, called ‘Company Evaluation Quadrant’, and identified as Visionary Leaders, Dynamic Differentiators, Innovators, or Emerging companies.

List of companies evaluated and profiled in the report:

3M
ADVANCED STERILIZATION PRODUCTS
BELIMED AG (SUBSIDIARY OF METALL ZUG GROUP)
CANTEL MEDICAL
ECOLAB
GETINGE
MATACHANA
MELAG MEDIZINTECHNIK OHG
METREX RESEARCH
(SUBSIDIARY OF THE DANAHER CORPORATION)
MMM GROUP
PAL INTERNATIONAL
RECKITT BENCKISER
SOTERA HEALTH LLC
STERIS
THE MIELE GROUP

Popular Reports This Week

Use 360 Insights to Beat Covid-19's Impact on your Revenues

You haven’t saved anything yet